With consumer health behind it, GSK taps AstraZeneca vet Julie Brown as CFO for R&D-focused future
Four years ago, Emma Walmsley recruited Iain Mackay from the banking world to become GSK’s CFO, spotlighting his “track record of driving cost, cash and capital allocation discipline to deliver strategy.” Now that he’s helped oversee the spinoff of GSK’s consumer health unit, Walmsley is turning to an industry veteran for his successor.
Julie Brown, a veteran of AstraZeneca who recently switched lanes to become Burberry’s chief operating and financial officer, will join GSK as CFO in April as Mackay retires.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 153,800+ biopharma pros reading Endpoints daily — and it's free.